🇺🇸 FDA
Patent

US 12390524

Compositions and methods for inducing immune responses

granted A61KA61K2039/507A61K2039/53

Quick answer

US patent 12390524 (Compositions and methods for inducing immune responses) held by ARCTURUS THERAPEUTICS, INC. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/507, A61K2039/53, A61K2039/55555, A61K2039/572